ACSS2 inhibitors (Curadev/University of Texas Southwestern)

N/A

Report date: 2025/01/26 18:36:52
NME

Base Information

Drug NameACSS2 inhibitors (Curadev/University of Texas Southwestern)
Drug Alias NameCRD-1400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetyl-coenzyme A synthetase, cytoplasmic inhibitors
TargetsAcetyl-coenzyme A synthetase, cytoplasmic
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCuradev Pharma Pvt Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A